Stocks to Watch Friday: Novo Nordisk, Hims, UnitedHealth, Dropbox
The Justice Department has launched an investigation into the company's Medicare billing practices, [The Wall Street Journal reported]( ...
Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...
Novo’s Ozempic Shortage Is Declared Over, Hitting Copycats
Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...
European Shares Notch Ninth Weekly Gain; Novo Nordisk Jumps
European stocks rose for a ninth straight week, boosted by shares of chemicals companies and Novo Nordisk A/S gains. Traders are also looking ahead to German elections on Sunday.
Why Novo Nordisk Is A Strong Buy Despite Market Concerns
Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...
STAT4d
Pharmalittle: We’re reading about Trump tariffs on drugs, a delayed Merck vaccine court trial, and more
President Trump told reporters that tariffs on pharmaceuticals would start at "25% or higher," but did not say when they ...